{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,29]],"date-time":"2026-10-29T03:51:43Z","timestamp":1793245903400,"version":"4.5.0"},"reference-count":84,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2022,8,1]],"date-time":"2022-08-01T00:00:00Z","timestamp":1659312000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,8,1]],"date-time":"2022-08-01T00:00:00Z","timestamp":1659312000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,8,1]],"date-time":"2022-08-01T00:00:00Z","timestamp":1659312000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2022,8,1]],"date-time":"2022-08-01T00:00:00Z","timestamp":1659312000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2022,8,1]],"date-time":"2022-08-01T00:00:00Z","timestamp":1659312000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2022,8,1]],"date-time":"2022-08-01T00:00:00Z","timestamp":1659312000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2022,8,1]],"date-time":"2022-08-01T00:00:00Z","timestamp":1659312000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/100019274","name":"National Institute of Mental Health and Neurosciences","doi-asserted-by":"publisher","award":["NIMH\/Proj\/BNS\/00555"],"award-info":[{"award-number":["NIMH\/Proj\/BNS\/00555"]}],"id":[{"id":"10.13039\/100019274","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001409","name":"Department of Science and Technology, Ministry of Science and Technology, India","doi-asserted-by":"publisher","award":["CRG\/2020\/005229"],"award-info":[{"award-number":["CRG\/2020\/005229"]}],"id":[{"id":"10.13039\/501100001409","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001409","name":"Department of Science and Technology, Ministry of Science and Technology, India","doi-asserted-by":"publisher","award":["ECR\/2015\/000545"],"award-info":[{"award-number":["ECR\/2015\/000545"]}],"id":[{"id":"10.13039\/501100001409","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001412","name":"Council of Scientific and Industrial Research, India","doi-asserted-by":"publisher","award":["09\/490(0102)\/2019-EMR-I"],"award-info":[{"award-number":["09\/490(0102)\/2019-EMR-I"]}],"id":[{"id":"10.13039\/501100001412","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001843","name":"Science and Engineering Research Board","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001843","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Steroids"],"published-print":{"date-parts":[[2022,8]]},"DOI":"10.1016\/j.steroids.2022.109058","type":"journal-article","created":{"date-parts":[[2022,6,6]],"date-time":"2022-06-06T11:07:51Z","timestamp":1654513671000},"page":"109058","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":10,"special_numbering":"C","title":["Mifepristone\u2019s effects on depression- and anxiety-like behavior in rodents"],"prefix":"10.1016","volume":"184","author":[{"given":"J.","family":"Nayana","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"B.S.","family":"Shankaranarayana Rao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"B.N.","family":"Srikumar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"3","key":"10.1016\/j.steroids.2022.109058_b0005","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1016\/0022-4731(85)90401-7","article-title":"RU 38486: A potent antiglucocorticoid in vitro and in vivo","volume":"23","author":"Gagne","year":"1985","journal-title":"J. Steroid Biochem."},{"issue":"1","key":"10.1016\/j.steroids.2022.109058_b0010","doi-asserted-by":"crossref","first-page":"7","DOI":"10.2165\/00003088-199733010-00002","article-title":"Clinical pharmacokinetics of mifepristone","volume":"33","author":"Heikinheimo","year":"1997","journal-title":"Clin. Pharmacokinet\/ [Internet]."},{"issue":"1","key":"10.1016\/j.steroids.2022.109058_b0015","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1016\/j.biopsych.2018.01.008","article-title":"Combined analysis of mifepristone for psychotic depression: plasma levels associated with clinical response","volume":"84","author":"Block","year":"2018","journal-title":"Biol. Psychiatry"},{"issue":"1","key":"10.1016\/j.steroids.2022.109058_b0020","first-page":"33","article-title":"Mifepristone (RU-486) treatment for depression and psychosis: a review of the therapeutic implications","volume":"2","author":"Gallagher","year":"2006","journal-title":"Neuropsychiatr. Dis. Treat."},{"issue":"2","key":"10.1016\/j.steroids.2022.109058_b0025","doi-asserted-by":"crossref","first-page":"143","DOI":"10.7326\/0003-4819-114-2-143","article-title":"Rapid reversal of acute psychosis in the cushing syndrome with the cortisol-receptor antagonist mifepristone (RU 486)","volume":"114","author":"Van Der Lely","year":"1991","journal-title":"Ann. Intern. Med."},{"issue":"10","key":"10.1016\/j.steroids.2022.109058_b0030","doi-asserted-by":"crossref","first-page":"1612","DOI":"10.1176\/appi.ajp.158.10.1612","article-title":"Cortisol activity and cognitive changes in psychotic major depression","volume":"158","author":"Belanoff","year":"2001","journal-title":"Am. J. Psychiatry"},{"key":"10.1016\/j.steroids.2022.109058_b0035","doi-asserted-by":"crossref","unstructured":"C.M. Blasey, C. DeBattista, R. Roe, T. Block, J.K. Belanoff. A multisite trial of mifepristone for the treatment of psychotic depression: A site-by-treatment interaction. Contemp Clin Trials [Internet]. 2009;30(4):284\u20138. doi:10.1016\/j.cct.2009.03.001.","DOI":"10.1016\/j.cct.2009.03.001"},{"issue":"1","key":"10.1016\/j.steroids.2022.109058_b0040","doi-asserted-by":"crossref","first-page":"71","DOI":"10.3109\/07853899309147861","article-title":"Dose-response relationships of RU 486","volume":"25","author":"Heikinheimo","year":"1993","journal-title":"Ann. Med. [Internet]."},{"key":"10.1016\/j.steroids.2022.109058_b0045","doi-asserted-by":"crossref","unstructured":"O. Heikinheimo. Pharmacokinetics of the antiprogesterone RU 486 in women during multiple dose administration. J Steroid Biochem. 1989;32(1 PART 1):21\u20135.","DOI":"10.1016\/0022-4731(89)90008-3"},{"issue":"5","key":"10.1016\/j.steroids.2022.109058_b0050","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1093\/oxfordjournals.humrep.a136554","article-title":"Metabolism and serum binding of RU 486 in women after various single doses","volume":"2","author":"Heikinheimo","year":"1987","journal-title":"Hum. Reprod."},{"issue":"1\u20133","key":"10.1016\/j.steroids.2022.109058_b0055","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1016\/j.jsbmb.2009.07.005","article-title":"Identification of the functional domain of glucocorticoid receptor involved in RU486 antagonism","volume":"117","author":"Lee","year":"2009","journal-title":"J. Steroid Biochem. Mol. Biol."},{"key":"10.1016\/j.steroids.2022.109058_b0060","doi-asserted-by":"crossref","unstructured":"R.L. Spencer, T. Deak. A users guide to HPA axis research. Physiol Behav [Internet]. 2017 Sep 1;178:43\u201365. doi:10.1016\/j.physbeh.2016.11.014.","DOI":"10.1016\/j.physbeh.2016.11.014"},{"issue":"9","key":"10.1016\/j.steroids.2022.109058_b0065","doi-asserted-by":"crossref","first-page":"813","DOI":"10.2174\/156802608784535011","article-title":"Glucocorticoid receptor antagonists","volume":"8","author":"Clark","year":"2008","journal-title":"Curr. Top. Med. Chem. [Internet]."},{"issue":"6","key":"10.1016\/j.steroids.2022.109058_b0070","doi-asserted-by":"crossref","first-page":"2039","DOI":"10.1210\/jc.2011-3350","article-title":"Mifepristone, a glucocorticoid receptor antagonist, produces clinical and metabolic benefits in patients with Cushing\u2019s syndrome","volume":"97","author":"Fleseriu","year":"2012","journal-title":"J. Clin. Endocrinol. Metab."},{"issue":"2","key":"10.1016\/j.steroids.2022.109058_b0075","doi-asserted-by":"crossref","first-page":"101","DOI":"10.3934\/molsci.2015.2.101","article-title":"Theory of partial agonist activity of steroid hormones","volume":"2","author":"Chow","year":"2015","journal-title":"AIMS Mol. Sci. [Internet]"},{"issue":"1","key":"10.1016\/j.steroids.2022.109058_b0080","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1210\/me.2003-0189","article-title":"Antiandrogen effects of mifepristone on coactivator and corepressor interactions with the androgen receptor","volume":"18","author":"Song","year":"2004","journal-title":"Mol. Endocrinol. [Internet]."},{"key":"10.1016\/j.steroids.2022.109058_b0085","doi-asserted-by":"crossref","unstructured":"G. Teutsch, D. Philibert. History and perspectives of antiprogestins from the chemist\u2019s point of view. Hum Reprod [Internet]. 1994 Jun;9 Suppl 1(Mer 25):12\u201331. Available from: http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/7962457.","DOI":"10.1093\/humrep\/9.suppl_1.12"},{"key":"10.1016\/j.steroids.2022.109058_b0090","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1146\/annurev.med.48.1.129","article-title":"RU486 (mifepristone): Mechanisms of action and clinical uses","volume":"48","author":"Cadepond","year":"1997","journal-title":"Annu. Rev. Med."},{"issue":"7","key":"10.1016\/j.steroids.2022.109058_b0095","doi-asserted-by":"crossref","first-page":"976","DOI":"10.1177\/1933719116671002","article-title":"Genomic and Nongenomic Effects of Mifepristone at the Cardiovascular Level: A Review","volume":"24","author":"Feiteiro","year":"2017","journal-title":"Reprod Sci."},{"issue":"8","key":"10.1016\/j.steroids.2022.109058_b0100","doi-asserted-by":"crossref","first-page":"6511","DOI":"10.1074\/jbc.M408972200","article-title":"The androgen receptor recruits nuclear receptor corepressor (N-CoR) in the presence of mifepristone via its N and C termini revealing a novel molecular mechanism for androgen receptor antagonists","volume":"280","author":"Hodgson","year":"2005","journal-title":"J. Biol. Chem."},{"issue":"10","key":"10.1016\/j.steroids.2022.109058_b0105","doi-asserted-by":"crossref","first-page":"3187","DOI":"10.1158\/1535-7163.MCT-08-0461","article-title":"Structural basis for nuclear receptor corepressor recruitment by antagonist-liganded androgen receptor","volume":"7","author":"Hodgson","year":"2008","journal-title":"Mol. Cancer Ther."},{"issue":"3","key":"10.1016\/j.steroids.2022.109058_b0110","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1093\/humupd\/dmi002","article-title":"Selective progesterone receptor modulators and progesterone antagonists: Mechanisms of action and clinical applications","volume":"11","author":"Chabbert-Buffet","year":"2005","journal-title":"Hum Reprod Update."},{"key":"10.1016\/j.steroids.2022.109058_b0115","doi-asserted-by":"crossref","unstructured":"S. Dalm, A.M. Karssen, O.C. Meijer, J.K. Belanoff, E.R. de Kloet. Resetting the Stress System with a Mifepristone Challenge. Cell Mol Neurobiol [Internet]. 2019 May;39(4):503\u201322. doi:10.1007\/s10571-018-0614-5.","DOI":"10.1007\/s10571-018-0614-5"},{"issue":"4","key":"10.1016\/j.steroids.2022.109058_b0120","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1210\/js.2016-1097","article-title":"Evaluation of Evidence of Adrenal Insufficiency in Trials of Normocortisolemic Patients Treated With Mifepristone","volume":"1","author":"Yuen","year":"2017","journal-title":"J. Endocr. Soc."},{"issue":"8","key":"10.1016\/j.steroids.2022.109058_b0125","doi-asserted-by":"crossref","first-page":"755","DOI":"10.1001\/archpsyc.57.8.755","article-title":"24-Hour monitoring of cortisol and corticotropin secretion in psychotic and nonpsychotic major depression","volume":"57","author":"Posener","year":"2000","journal-title":"Arch. Gen. Psychiatry"},{"key":"10.1016\/j.steroids.2022.109058_b0130","doi-asserted-by":"crossref","unstructured":"F. Duval, M.C. Mokrani, M.A. Crocq, P.E. Bailey, T.S. Diep, H. Correa et al. Dopaminergic function and the cortisol response to dexamethasone in psychotic depression. 2000;24.","DOI":"10.1016\/S0278-5846(99)00098-6"},{"issue":"9","key":"10.1016\/j.steroids.2022.109058_b0135","doi-asserted-by":"crossref","first-page":"985","DOI":"10.1038\/sj.mp.4001139","article-title":"Regional specificity of brain glucocorticoid receptor mRNA alterations in subjects with schizophrenia and mood disorders","volume":"7","author":"Webster","year":"2002","journal-title":"Mol. Psychiatry"},{"key":"10.1016\/j.steroids.2022.109058_b0140","doi-asserted-by":"crossref","unstructured":"Y.I. Sheline, P.O.W. Wang, M.H. Gadots, J.G. Csernansky, Hippocampal atrophy in recurrent major depression. 1996;93(April):3908\u201313.","DOI":"10.1073\/pnas.93.9.3908"},{"key":"10.1016\/j.steroids.2022.109058_b0145","doi-asserted-by":"crossref","unstructured":"L. Taekwan, J. Tim, L. Shi-Jiang, J.K. Jeansok, J HF. Chronic stress selectively reduces hippocampal volume in rats: a longitudinal magnetic resonance imaging study. 2009;i(17):1554\u20138.","DOI":"10.1097\/WNR.0b013e328332bb09"},{"key":"10.1016\/j.steroids.2022.109058_b0150","doi-asserted-by":"crossref","unstructured":"G.A. Carrasco, Kar LD Van De. Neuroendocrine pharmacology of stress. 2003;463:235\u201372.","DOI":"10.1016\/S0014-2999(03)01285-8"},{"issue":"3","key":"10.1016\/j.steroids.2022.109058_b0155","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1002\/hup.2731","article-title":"Progesterone loading as a strategy for treating postpartum depression","volume":"35","author":"Barak","year":"2020","journal-title":"Hum. Psychopharmacol."},{"key":"10.1016\/j.steroids.2022.109058_b0160","doi-asserted-by":"crossref","unstructured":"C.A. Frye. Progesterone attenuates depressive behavior of younger and older adult C57\/BL6, wildtype, and progesterone receptor knockout mice. Pharmacol Biochem Behav [Internet]. 2011;99(4):525\u201331. doi:10.1016\/j.pbb.2011.05.024.","DOI":"10.1016\/j.pbb.2011.05.024"},{"issue":"6","key":"10.1016\/j.steroids.2022.109058_b0165","doi-asserted-by":"crossref","first-page":"824","DOI":"10.1016\/j.psyneuen.2010.11.004","article-title":"Progesterone receptor antagonist CDB-4124 increases depression-like behavior in mice without affecting locomotor ability","volume":"36","author":"Beckley","year":"2011","journal-title":"Psychoneuroendocrinology."},{"key":"10.1016\/j.steroids.2022.109058_b0170","doi-asserted-by":"crossref","unstructured":"S. Benmansour, R.S. Weaver, A.K. Barton, O.S. Adeniji, A. Frazer. Comparison of the effects of estradiol and progesterone on serotonergic function. Biol Psychiatry [Internet]. 2012;71(7):633\u201341. doi:10.1016\/j.biopsych.2011.11.023.","DOI":"10.1016\/j.biopsych.2011.11.023"},{"issue":"9","key":"10.1016\/j.steroids.2022.109058_b0175","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3390\/cells8091021","article-title":"Deficiency in androgen receptor aggravates the depressive-like behaviors in chronic mild stress model of depression","volume":"8","author":"Hung","year":"2019","journal-title":"Cells."},{"key":"10.1016\/j.steroids.2022.109058_b0180","doi-asserted-by":"crossref","unstructured":"J.S. Sankar, E. Hampson. Testosterone levels and androgen receptor gene polymorphism predict specific symptoms of depression in young men. Gend Med [Internet]. 2012;9(4):232\u201343. doi:10.1016\/j.genm.2012.05.001.","DOI":"10.1016\/j.genm.2012.05.001"},{"issue":"3","key":"10.1016\/j.steroids.2022.109058_b0185","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1097\/JGP.0b013e3181e70c22","article-title":"Depressive symptoms in men aged 50 years and older and their relationship to genetic androgen receptor polymorphism and sex hormone levels in three different samples","volume":"19","author":"Schneider","year":"2011","journal-title":"Am. J. Geriatr. Psychiatry."},{"issue":"10","key":"10.1016\/j.steroids.2022.109058_b0190","doi-asserted-by":"crossref","first-page":"2083","DOI":"10.1016\/j.psyneuen.2013.03.016","article-title":"The relation between sex hormone levels, the androgen receptor CAGn-polymorphism and depression and mortality in older men in a community study","volume":"38","author":"Schneider","year":"2013","journal-title":"Psychoneuroendocrinology."},{"issue":"5","key":"10.1016\/j.steroids.2022.109058_b0195","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1016\/S0006-3223(01)01148-9","article-title":"Testosterone level, androgen receptor polymorphism, and depressive symptoms in middle-aged men","volume":"50","author":"Seidman","year":"2001","journal-title":"Biol. Psychiatry"},{"issue":"5","key":"10.1016\/j.steroids.2022.109058_b0200","doi-asserted-by":"crossref","first-page":"2491","DOI":"10.1210\/jc.2003-031945","article-title":"Low-dose mifepristone inhibits endometrial proliferation and up-regulates androgen receptor","volume":"89","author":"Narvekar","year":"2004","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.steroids.2022.109058_b0205","doi-asserted-by":"crossref","unstructured":"Y. Wang, W. He, H. Zhang, Z. Yao, F. Che, Y. Cao, et al. mGluR5 mediates ketamine antidepressant response in susceptible rats exposed to prenatal stress. J Affect Disord [Internet]. 2020 Jul;272(January):398\u2013408. doi:10.1016\/j.jad.2020.03.104.","DOI":"10.1016\/j.jad.2020.03.104"},{"key":"10.1016\/j.steroids.2022.109058_b0210","doi-asserted-by":"crossref","unstructured":"S.M. Korte, E.R. De Kloet, B. Buwalda, S.D. Bouman, B. Bohus. Antisense to the glucocorticoid receptor in hippocampal dentate gyrus reduces immobility in forced swim test. Vol. 301, European Journal of Pharmacology. 1996. p. 19\u201325.","DOI":"10.1016\/0014-2999(96)00064-7"},{"key":"10.1016\/j.steroids.2022.109058_b0215","doi-asserted-by":"crossref","unstructured":"M. Iijima, A. Ito, S. Kurosu, S. Chaki. Pharmacological characterization of repeated corticosterone injection-induced depression model in rats. Brain Res [Internet]. 2010 Nov 4;1359:75\u201380. doi:10.1016\/j.brainres.2010.08.078.","DOI":"10.1016\/j.brainres.2010.08.078"},{"issue":"2\u20133","key":"10.1016\/j.steroids.2022.109058_b0220","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1016\/0014-2999(85)90693-4","article-title":"Glucocorticoids facilitate the retention of acquired immobility during forced swimming","volume":"115","author":"Veldhuis","year":"1985","journal-title":"Eur, J, Pharmacol, [Internet]."},{"key":"10.1016\/j.steroids.2022.109058_b0225","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1016\/j.expneurol.2018.05.024","article-title":"Stress modulates cortical excitability via \u03b1-2 adrenergic and glucocorticoid receptors: As assessed by spreading depression","volume":"307","author":"Yap\u0131c\u0131-Eser","year":"2018","journal-title":"Exp. Neurol."},{"key":"10.1016\/j.steroids.2022.109058_b0230","doi-asserted-by":"crossref","unstructured":"A.C. Wulsin, J.P. Herman, M.B. Solomon. Mifepristone decreases depression-like behavior and modulates neuroendocrine and central hypothalamic-pituitary-adrenocortical axis responsiveness to stress. Psychoneuroendocrinology [Internet]. 2010;35(7):1100\u201312. doi:10.1016\/j.psyneuen.2010.01.011.","DOI":"10.1016\/j.psyneuen.2010.01.011"},{"key":"10.1016\/j.steroids.2022.109058_b0235","doi-asserted-by":"crossref","unstructured":"M.S. Lee, W.S. Park, Y.H. Kim, S.H. Kwon, Y.J. Jang, D. Han, et al. Antidepressant-like effects of Cortex Mori Radicis extract via bidirectional phosphorylation of glucocorticoid receptors in the hippocampus. Behav Brain Res [Internet]. 2013;236(1):56\u201361. doi:10.1016\/j.bbr.2012.08.028.","DOI":"10.1016\/j.bbr.2012.08.028"},{"issue":"6","key":"10.1016\/j.steroids.2022.109058_b0240","doi-asserted-by":"crossref","first-page":"2709","DOI":"10.1210\/en.2008-1211","article-title":"Postnatal glucocorticoid excess due to pituitary glucocorticoid receptor deficiency: differential short- and long-term consequences","volume":"150","author":"Schmidt","year":"2009","journal-title":"Endocrinology"},{"key":"10.1016\/j.steroids.2022.109058_b0245","doi-asserted-by":"crossref","unstructured":"D. Wang, W. Lin, Y. Pan, X. Kuang, X. Qi, H. Sun. Chronic blockade of glucocorticoid receptors by RU486 enhances lipopolysaccharide-induced depressive-like behaviour and cytokine production in rats. Brain Behav Immun [Internet]. 2011;25(4):706\u201314. doi:10.1016\/j.bbi.2011.01.011.","DOI":"10.1016\/j.bbi.2011.01.011"},{"issue":"5","key":"10.1016\/j.steroids.2022.109058_b0250","doi-asserted-by":"crossref","first-page":"1305","DOI":"10.1038\/npp.2011.319","article-title":"Gap junction dysfunction in the prefrontal cortex induces depressive-like behaviors in rats","volume":"37","author":"Sun","year":"2012","journal-title":"Neuropsychopharmacology."},{"key":"10.1016\/j.steroids.2022.109058_b0255","doi-asserted-by":"crossref","unstructured":"J. Xu, R. Wang, Y. Liu, D. Liu, H. Jiang, F. Pan. FKBP5 and specific microRNAs via glucocorticoid receptor in the basolateral amygdala involved in the susceptibility to depressive disorder in early adolescent stressed rats. J Psychiatr Res [Internet]. 2017;95:102\u201313. doi:10.1016\/j.jpsychires.2017.08.010.","DOI":"10.1016\/j.jpsychires.2017.08.010"},{"issue":"9","key":"10.1016\/j.steroids.2022.109058_b0260","doi-asserted-by":"crossref","first-page":"2529","DOI":"10.1007\/s00213-018-4936-2","article-title":"Glucocorticoid receptor activation induces decrease of hippocampal astrocyte number in rats","volume":"235","author":"Lou","year":"2018","journal-title":"Psychopharmacology"},{"key":"10.1016\/j.steroids.2022.109058_b0265","doi-asserted-by":"crossref","unstructured":"M.B. Solomon, A.C. Wulsin, T. Rice, D. Wick, B. Myers, J. McKlveen, et al. The selective glucocorticoid receptor antagonist CORT 108297 decreases neuroendocrine stress responses and immobility in the forced swim test. Horm Behav [Internet]. 2014;65(4):363\u201371. doi:10.1016\/j.yhbeh.2014.02.002.","DOI":"10.1016\/j.yhbeh.2014.02.002"},{"key":"10.1016\/j.steroids.2022.109058_b0270","doi-asserted-by":"crossref","first-page":"436","DOI":"10.1016\/j.bbr.2018.03.033","article-title":"Mifepristone attenuates depression-like changes induced by chronic central administration of interleukin-1\u03b2 in rats","volume":"347","author":"Zhang","year":"2018","journal-title":"Behav. Brain Res."},{"issue":"2","key":"10.1016\/j.steroids.2022.109058_b0275","doi-asserted-by":"crossref","first-page":"304","DOI":"10.1016\/0006-8993(93)90042-L","article-title":"Effects of the antiglucocorticoid RU 38486 on the induction of learned helpless behavior in Sprague-Dawley rats","volume":"615","author":"Papolos","year":"1993","journal-title":"Brain Res [Internet]."},{"key":"10.1016\/j.steroids.2022.109058_b0280","doi-asserted-by":"crossref","unstructured":"S. Ghosal, J. Bundzikova-Osacka, C.M. Dolgas, B. Myers, J.P. Herman. Glucocorticoid receptors in the nucleus of the solitary tract (NTS) decrease endocrine and behavioral stress responses. Psychoneuroendocrinology [Internet]. 2014;45:142\u201353. doi:10.1016\/j.psyneuen.2014.03.018.","DOI":"10.1016\/j.psyneuen.2014.03.018"},{"issue":"12","key":"10.1016\/j.steroids.2022.109058_b0285","doi-asserted-by":"crossref","first-page":"2500","DOI":"10.1038\/sj.npp.1301386","article-title":"Mifepristone repairs region-dependent alteration of synapsin I in hippocampus in rat model of depression","volume":"32","author":"Wu","year":"2007","journal-title":"Neuropsychopharmacology."},{"key":"10.1016\/j.steroids.2022.109058_b0290","doi-asserted-by":"crossref","unstructured":"E.T. Nguyen, J. Streicher, S. Berman, J.L. Caldwell, V. Ghisays, C.M. Estrada, et al. A mixed glucocorticoid\/mineralocorticoid receptor modulator dampens endocrine and hippocampal stress responsivity in male rats. Physiol Behav [Internet]. 2017 Sep 1;178:82\u201392. doi:10.1016\/j.physbeh.2017.01.020.","DOI":"10.1016\/j.physbeh.2017.01.020"},{"issue":"6","key":"10.1016\/j.steroids.2022.109058_b0295","first-page":"G1622","article-title":"Corticosteroid receptor-mediated mechanisms in the amygdala regulate anxiety and colonic sensitivity","volume":"292","author":"Myers","year":"2007","journal-title":"Am. J. Physiol. Liver Physiol."},{"issue":"9","key":"10.1016\/j.steroids.2022.109058_b0300","doi-asserted-by":"crossref","first-page":"962","DOI":"10.1002\/gps.4085","article-title":"Antiglucocorticoid therapy for older adults with anxiety and co-occurring cognitive dysfunction: Results from a pilot study with mifepristone","volume":"29","author":"Lenze","year":"2014","journal-title":"Int. J. Geriatr Psychiatry."},{"issue":"5","key":"10.1016\/j.steroids.2022.109058_b0305","doi-asserted-by":"crossref","first-page":"851","DOI":"10.1586\/14737175.4.5.851","article-title":"Role of progesterone and other neuroactive steroids in anxiety disorders","volume":"4","author":"Le Mell\u00e9do","year":"2004","journal-title":"Expert Rev. Neurother."},{"issue":"12","key":"10.1016\/j.steroids.2022.109058_b0310","first-page":"1049","article-title":"Association of acne, hirsutism, androgen, anxiety, and depression on cognitive performance in polycystic ovary syndrome: A cross-sectional study","volume":"18","author":"Mehrabadi","year":"2020","journal-title":"Int. J. Reprod. Biomed."},{"issue":"3","key":"10.1016\/j.steroids.2022.109058_b0315","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1111\/jnc.12459","article-title":"Corticosterone administration upregulated expression of norepinephrine transporter and dopamine \u03b2-hydroxylase in rat locus coeruleus and its terminal regions","volume":"128","author":"Fan","year":"2014","journal-title":"J. Neurochem."},{"key":"10.1016\/j.steroids.2022.109058_b0320","doi-asserted-by":"crossref","unstructured":"J. Ding, M.S. da Silva, J. Lingeman, X. Chen, Y. Shi, F. Han, et al. Late glucocorticoid receptor antagonism changes the outcome of adult life stress. Psychoneuroendocrinology [Internet]. 2019;107(77):169\u201378. doi:10.1016\/j.psyneuen.2019.05.014.","DOI":"10.1016\/j.psyneuen.2019.05.014"},{"issue":"3","key":"10.1016\/j.steroids.2022.109058_b0325","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1016\/S0091-3057(96)00244-4","article-title":"Hippocampal mineralocorticoid, but not glucocorticoid, receptors modulate anxiety-like behavior in rats","volume":"56","author":"Smythe","year":"1997","journal-title":"Pharmacol. Biochem. Behav."},{"issue":"4","key":"10.1016\/j.steroids.2022.109058_b0330","doi-asserted-by":"crossref","first-page":"320","DOI":"10.1097\/FBP.0b013e3283637de2","article-title":"Blockade of corticosteroid receptors induces anxiolytic-like effects in streptozotocin-induced diabetic mice, and synergizes with diazepam","volume":"24","author":"L\u00f3pez-Rubalcava","year":"2013","journal-title":"Behav. Pharmacol."},{"key":"10.1016\/j.steroids.2022.109058_b0335","doi-asserted-by":"crossref","unstructured":"A. Mouri, M. Ukai, M. Uchida, S. Hasegawa, M. Taniguchi, T. Ito, et al. Juvenile social defeat stress exposure persistently impairs social behaviors and neurogenesis. Neuropharmacology [Internet]. 2018;133:23\u201337. doi:10.1016\/j.neuropharm.2018.01.016.","DOI":"10.1016\/j.neuropharm.2018.01.016"},{"issue":"4","key":"10.1016\/j.steroids.2022.109058_b0340","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1159\/000054643","article-title":"Glucocorticoid and mineralocorticoid receptors are involved in the facilitation of anxiety-like response induced by restraint","volume":"73","author":"Calvo","year":"2001","journal-title":"Neuroendocrinology"},{"issue":"4","key":"10.1016\/j.steroids.2022.109058_b0345","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1016\/0306-4530(94)00069-7","article-title":"Anxiolytic-like effects of selective mineralocorticoid and glucocorticoid antagonists on fear-enhanced behavior in the elevated plus-maze","volume":"20","author":"Korte","year":"1995","journal-title":"Psychoneuroendocrinology [Internet]."},{"issue":"5","key":"10.1016\/j.steroids.2022.109058_b0350","doi-asserted-by":"crossref","first-page":"1049","DOI":"10.1038\/sj.npp.1301498","article-title":"Androgen administration to aged male mice increases anti-anxiety behavior and enhances cognitive performance","volume":"33","author":"Frye","year":"2008","journal-title":"Neuropsychopharmacology [Internet]."},{"issue":"4","key":"10.1016\/j.steroids.2022.109058_b0355","doi-asserted-by":"crossref","first-page":"879","DOI":"10.1016\/S0091-3057(98)00071-9","article-title":"Corticosterone is permissive to the anxiolytic effect that results from the blockade of hippocampal mineralocorticoid receptors","volume":"60","author":"Bitran","year":"1998","journal-title":"Pharmacol. Biochem. Behav."},{"key":"10.1016\/j.steroids.2022.109058_b0360","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1016\/0091-3057(95)02172-8","article-title":"Mineralocorticoid and glucocorticoid receptor antagonists in animal models of anxiety","author":"Korte","year":"1996","journal-title":"Pharmacol. Biochem. Behav. [Internet]"},{"key":"10.1016\/j.steroids.2022.109058_b0365","doi-asserted-by":"crossref","unstructured":"M. Jakovcevski, M. Schachner, F. Morellini. Susceptibility to the long-term anxiogenic effects of an acute stressor is mediated by the activation of the glucocorticoid receptors. Neuropharmacology [Internet]. 2011;61(8):1297\u2013305. doi:10.1016\/j.neuropharm.2011.07.034.","DOI":"10.1016\/j.neuropharm.2011.07.034"},{"key":"10.1016\/j.steroids.2022.109058_b0370","doi-asserted-by":"crossref","unstructured":"Fox LC, Davies DR, Scholl JL, Watt MJ, Forster GL. Differential effects of glucocorticoid and mineralocorticoid antagonism on anxiety behavior in mild traumatic brain injury. Behav Brain Res [Internet]. 2016;312:362\u20135. Available from: http:\/\/dx.doi.org\/10.1016\/j.bbr.2016.06.048.","DOI":"10.1016\/j.bbr.2016.06.048"},{"issue":"3","key":"10.1016\/j.steroids.2022.109058_b0375","doi-asserted-by":"crossref","first-page":"1098","DOI":"10.1159\/000478764","article-title":"RU486 Reverses Emotional Disorders by Influencing Astrocytes and Endoplasmic Reticulum Stress in Chronic Restraint Stress Challenged Rats","volume":"42","author":"Dong","year":"2017","journal-title":"Cell. Physiol. Biochem."},{"key":"10.1016\/j.steroids.2022.109058_b0380","doi-asserted-by":"crossref","unstructured":"Verdouw PM, van Esterik JCJ, Peeters BWMM, Millan MJ, Groenink L. CRF1 but not glucocorticoid receptor antagonists reduce separation-induced distress vocalizations in guinea pig pups and CRF overexpressing mouse pups. A combination study with paroxetine. Pharmacol Biochem Behav [Internet]. 2017;154:11\u20139. Available from: http:\/\/dx.doi.org\/10.1016\/j.pbb.2017.01.003.","DOI":"10.1016\/j.pbb.2017.01.003"},{"issue":"11","key":"10.1016\/j.steroids.2022.109058_b0385","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0003606","article-title":"Progestin receptor-mediated reduction of anxiety-like behavior in male rats","volume":"3","author":"Auger","year":"2008","journal-title":"PLoS ONE"},{"issue":"18","key":"10.1016\/j.steroids.2022.109058_b0390","doi-asserted-by":"crossref","first-page":"6983","DOI":"10.1523\/JNEUROSCI.20-18-06983.2000","article-title":"Neurobiological correlates of individual differences in novelty-seeking behavior in the rat: differential expression of stress-related molecules","volume":"20","author":"Kabbaj","year":"2000","journal-title":"J Neurosci [Internet]."},{"issue":"2","key":"10.1016\/j.steroids.2022.109058_b0395","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1016\/j.bbr.2007.02.001","article-title":"Involvement of noradrenergic and corticoid receptors in the consolidation of the lasting anxiogenic effects of predator stress","volume":"179","author":"Adamec","year":"2007","journal-title":"Behav. Brain Res."},{"issue":"21","key":"10.1016\/j.steroids.2022.109058_b0400","doi-asserted-by":"crossref","DOI":"10.3390\/ijms21218212","article-title":"HIV-1 Tat Dysregulates the Hypothalamic-Pituitary-Adrenal Stress Axis and Potentiates Oxycodone-Mediated Psychomotor and Anxiety-Like Behavior of Male Mice","volume":"21","author":"Salahuddin","year":"2020","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.steroids.2022.109058_b0405","doi-asserted-by":"crossref","unstructured":"C. Jacquot, A.P. Croft, M.A. Prendergast, P. Mulholland, S.G. Shaw, H.J. Little. Effects of the Glucocorticoid Antagonist , Mifepristone , on the Consequences of Withdrawal From Long Term Alcohol Consumption. 2008;32(12):2107\u201316.","DOI":"10.1111\/j.1530-0277.2008.00799.x"},{"issue":"11","key":"10.1016\/j.steroids.2022.109058_b0410","doi-asserted-by":"crossref","first-page":"891","DOI":"10.1111\/j.1365-2826.2007.01605.x","article-title":"Effect of the glucocorticoid receptor antagonist Org 34850 on basal and stress-induced corticosterone secretion","volume":"19","author":"Spiga","year":"2007","journal-title":"J. Neuroendocrinol."},{"issue":"2","key":"10.1016\/j.steroids.2022.109058_b0415","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1677\/JOE-07-0503","article-title":"Effect of the glucocorticoid receptor antagonist Org 34850 on fast and delayed feedback of corticosterone release","volume":"196","author":"Spiga","year":"2008","journal-title":"J. Endocrinol."},{"issue":"1","key":"10.1016\/j.steroids.2022.109058_b0420","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1530\/JOE-19-0486","article-title":"The selective glucocorticoid receptor antagonist CORT125281 has tissue-specific activity","volume":"246","author":"Koorneef","year":"2020","journal-title":"J. Endocrinol."}],"container-title":["Steroids"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0039128X22000964?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0039128X22000964?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,22]],"date-time":"2025-09-22T10:09:19Z","timestamp":1758535759000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0039128X22000964"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,8]]},"references-count":84,"alternative-id":["S0039128X22000964"],"URL":"https:\/\/doi.org\/10.1016\/j.steroids.2022.109058","relation":{},"ISSN":["0039-128X"],"issn-type":[{"value":"0039-128X","type":"print"}],"subject":[],"published":{"date-parts":[[2022,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Mifepristone\u2019s effects on depression- and anxiety-like behavior in rodents","name":"articletitle","label":"Article Title"},{"value":"Steroids","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.steroids.2022.109058","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"109058"}}